Nurix Therapeutics, Inc.
NASDAQ:NRIX
24.74 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash & Cash Equivalents
| 116.79 | 49.813 | 54.627 | 42.304 | 58.958 | 33.571 | 64.474 | 47.556 | 41.533 | 78.78 | 80.506 | 147.44 | 188.207 | 126.381 | 119.356 | 265.527 | 159.329 | 56.41 | 34.816 | -39.039 |
| Short Term Investments
| 326.349 | 194.18 | 233.281 | 216.548 | 222.219 | 243.575 | 244.667 | 296.922 | 255.746 | 183.198 | 215.214 | 196.458 | 197.814 | 176.692 | 161.792 | 88.716 | 14.174 | 14.937 | 2.904 | 78.078 |
| Cash and Short Term Investments
| 443.139 | 243.993 | 287.908 | 258.852 | 281.177 | 277.146 | 309.141 | 344.478 | 297.279 | 261.978 | 295.72 | 343.898 | 386.021 | 303.073 | 281.148 | 354.243 | 173.503 | 71.347 | 37.72 | 39.039 |
| Net Receivables
| 0.6 | 0.8 | 0.8 | 2 | 1 | 1.2 | 1.1 | 1.1 | 0.7 | 8.204 | 6.204 | 5.204 | 5.679 | 3.981 | 11.346 | 3.856 | 19.59 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | -1 | -1.2 | -1.1 | -1.1 | -0.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.478 | 6.176 | 6.795 | 7.097 | 8.837 | 11.183 | 9.308 | 10.393 | 9.51 | 10.302 | 9.194 | 9.343 | 4.581 | 3.714 | 5.94 | 5.99 | 3.711 | 5.313 | 1.634 | 0 |
| Total Current Assets
| 450.217 | 250.969 | 295.503 | 267.949 | 290.014 | 288.329 | 318.449 | 354.871 | 306.789 | 280.484 | 311.118 | 358.445 | 396.281 | 310.768 | 298.434 | 364.089 | 196.804 | 76.66 | 39.354 | 39.039 |
| Non-Current Assets: | ||||||||||||||||||||
| Property, Plant & Equipment, Net
| 47.392 | 47.17 | 47.95 | 25.608 | 28.436 | 28.634 | 29.508 | 30.349 | 30.925 | 29.394 | 25.345 | 9.569 | 8.345 | 6.96 | 6.672 | 6.532 | 5.789 | 3.975 | 3.871 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | -3.301 | 0 | 0 | 0 | -3.326 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 10.281 | 11.193 | 8.322 | 9.882 | 27.463 | 48.449 | 63.879 | 69.125 | 51.538 | 123.685 | 137.189 | 121.48 | 110.44 | 77.191 | 90.89 | 40.898 | 9.11 | 7.584 | 0.506 | 0 |
| Tax Assets
| 0 | 0 | 8.941 | 0 | 0 | 0 | 3.301 | 0 | 0 | 0 | 3.326 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.141 | 3.342 | 3.823 | 4.756 | 4.711 | 4.742 | 4.923 | 4.993 | 5.058 | 4.157 | -0.207 | 3.58 | 2.915 | 1.741 | 0.347 | 0.355 | 1.574 | 0.57 | 0.317 | -39.039 |
| Total Non-Current Assets
| 60.814 | 61.705 | 69.036 | 40.246 | 60.61 | 81.825 | 98.31 | 104.467 | 87.521 | 157.236 | 165.653 | 134.629 | 121.7 | 85.892 | 97.909 | 47.785 | 16.473 | 12.129 | 4.694 | -39.039 |
| Total Assets
| 511.031 | 312.674 | 364.539 | 308.195 | 350.624 | 370.154 | 416.759 | 459.338 | 394.31 | 437.72 | 476.771 | 493.074 | 517.981 | 396.66 | 396.343 | 411.874 | 213.277 | 88.789 | 44.048 | 0 |
| Liabilities & Equity: | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Account Payables
| 2.813 | 5.918 | 6.401 | 2.187 | 4.525 | 5.629 | 5.064 | 6.053 | 6.142 | 6.014 | 6.65 | 3.861 | 5.405 | 4.388 | 3.412 | 3.611 | 4.903 | 2.127 | 1.598 | 0 |
| Short Term Debt
| 7.934 | 7.31 | 7.489 | 5.362 | 5.583 | 5.556 | 5.53 | 5.496 | 5.47 | 5.43 | 3.847 | 10.941 | 7.077 | 10.137 | 7.628 | 6.144 | 3.927 | 0 | 4.618 | 0 |
| Tax Payables
| 0.71 | 0.427 | 0.03 | 0.034 | 0.016 | 0.089 | 0.085 | 0.041 | 0.026 | 0.053 | 0.075 | 0.037 | 0 | 0.325 | 0.074 | 0 | 0 | 0 | 0.033 | 0 |
| Deferred Revenue
| 46.769 | 46.077 | 48.098 | 32.037 | 44.063 | 38.305 | 37.633 | 36.342 | 41.319 | 43.186 | 41.212 | 35.25 | 33.761 | 32.751 | 32.799 | 30.299 | 25.372 | 0 | 9.612 | 0 |
| Other Current Liabilities
| 23.263 | 28.318 | 24.97 | 21.907 | 18.091 | 15.388 | 22.428 | 19.609 | 19.734 | 11.419 | 14.549 | 0.628 | 0.601 | 0.696 | 0.7 | 0.958 | 0.234 | 27.906 | 0.309 | 0 |
| Total Current Liabilities
| 80.779 | 87.623 | 86.958 | 61.493 | 72.262 | 64.878 | 70.655 | 67.5 | 72.665 | 66.049 | 66.258 | 50.68 | 46.844 | 47.972 | 44.539 | 41.012 | 34.436 | 30.033 | 16.137 | 0 |
| Non-Current Liabilities: | ||||||||||||||||||||
| Long Term Debt
| 20.885 | 21.846 | 23.125 | 2.642 | 3.758 | 5.106 | 6.434 | 7.745 | 9.043 | 10.326 | 9.189 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 38.674 | 34.457 | 45.022 | 10.243 | 14.683 | 26.118 | 35.974 | 41.548 | 45.863 | 55.428 | 59.022 | 66.381 | 72.122 | 77.723 | 60.685 | 62.374 | 71.387 | 0 | 35.693 | 0 |
| Deferred Tax Liabilities Non-Current
| -38.674 | 0 | 8.941 | -10.243 | -14.683 | -26.118 | 3.301 | -41.548 | -45.863 | -55.428 | 3.326 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 38.674 | -0 | 0 | 10.243 | 14.683 | 26.118 | -3.301 | 41.548 | 45.863 | 0 | -3.326 | 0.796 | 0.837 | 0.832 | 0.85 | 0.868 | 0.871 | 0 | 49.932 | 0 |
| Total Non-Current Liabilities
| 59.559 | 56.303 | 77.088 | 12.885 | 18.441 | 31.224 | 42.408 | 49.293 | 54.906 | 65.754 | 68.211 | 67.177 | 72.959 | 78.555 | 61.535 | 63.242 | 72.258 | 0 | 85.625 | 0 |
| Total Liabilities
| 140.338 | 143.926 | 164.046 | 74.378 | 90.703 | 96.102 | 113.063 | 116.793 | 127.571 | 131.803 | 134.469 | 117.857 | 119.803 | 126.527 | 106.074 | 104.254 | 106.694 | 30.033 | 101.762 | 0 |
| Equity: | ||||||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 396.343 | 411.874 | 168.109 | 48.195 | 48.195 | 48.195 |
| Common Stock
| 0.064 | 0.049 | 0.049 | 0.049 | 0.048 | 0.047 | 0.047 | 0.047 | 0.045 | 0.045 | 0.045 | 0.045 | 0.044 | 0.039 | 0.039 | 0.039 | 0.026 | 0.011 | 0.004 | 0 |
| Retained Earnings
| -631.264 | -586.718 | -545.2 | -503.244 | -466.262 | -441.985 | -401.252 | -354.535 | -308.826 | -263.425 | -220.892 | -183.19 | -154.355 | -127.973 | -103.698 | -83.784 | -65.267 | -72.847 | -60.456 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -0.135 | -0.35 | -0.655 | -1.228 | -1.903 | -3.247 | -4.319 | -3.742 | -3.085 | -2.066 | -0.608 | -0.059 | 0.03 | 0.049 | 0.087 | 0.138 | 0.139 | 0.057 | -0.002 | -36.847 |
| Other Total Stockholders Equity
| 1,002.028 | 755.767 | 746.299 | 738.24 | 728.038 | 719.237 | 709.22 | 700.775 | 578.605 | 571.363 | 563.757 | 558.421 | 552.459 | 398.018 | -2.502 | -20.647 | 3.576 | 2.977 | -45.455 | 0 |
| Total Shareholders Equity
| 370.693 | 168.748 | 200.493 | 233.817 | 259.921 | 274.052 | 303.696 | 342.545 | 266.739 | 305.917 | 342.302 | 375.217 | 398.178 | 270.133 | 290.269 | 307.62 | 106.583 | -21.607 | -57.714 | 11.348 |
| Total Equity
| 370.693 | 168.748 | 200.493 | 233.817 | 259.921 | 274.052 | 303.696 | 342.545 | 266.739 | 305.917 | 342.302 | 375.217 | 398.178 | 270.133 | 290.269 | 307.62 | 106.583 | -21.607 | -57.714 | 11.348 |
| Total Liabilities & Shareholders Equity
| 511.031 | 312.674 | 364.539 | 308.195 | 350.624 | 370.154 | 416.759 | 459.338 | 394.31 | 437.72 | 476.771 | 493.074 | 517.981 | 396.66 | 396.343 | 411.874 | 213.277 | 8.426 | 44.048 | 11.348 |